Aspirin use in adults cancer, all-cause mortality, and harms : a systematic evidence review for the U.S. Preventive Services Task Force

When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI, 1.00 to 1.75]). Relatively rare events limited analyses. Data from cohort studies indicated that baseline rates of serious bleeding are higher than suggested from trials, and data from trials as well as c...

Full description

Bibliographic Details
Main Authors: Whitlock, Evelyn P., Williams, Selvi (Author), Burda, Brittany U. (Author), Feightner, Alisha (Author)
Corporate Authors: United States Agency for Healthcare Research and Quality, U.S. Preventive Services Task Force, Oregon Evidence-based Practice Center (Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region))
Format: eBook
Published: Rockville, MD Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [2015], 2015
Series:Evidence synthesis
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references